| J3380 | Injection, vedolizumab, intravenous, 1 mg | 17,400 | $20 | $295.8K |
| J0897 | Injection, denosumab, 1 mg | 16,080 | $20 | $289.5K |
| J3262 | Injection, tocilizumab, 1 mg | 26,760 | $10 | $133.8K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,350 | $30 | $113.9K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,590 | $30 | $77.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 540 | $100 | $53K |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 240 | $100 | $23.8K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 290 | $70 | $20.2K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 340 | $60 | $19.3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 90 | $140 | $11.7K |